Edmund F. Mrak Jr

FDA investigator

Appears on 7 documents from 2012 to 2022, most often at sites in Massachusetts. Most often cites general requirements (21 CFR 211.160).

7
Documents on file
4.8
Observations per 483
2012
First seen
2022
Most recent

What they cite most

From 33 observations

Activity by year

2012: 1, 2014: 1, 2016: 3, 2022: 2

Where

Massachusetts 3 · India 1 · New Jersey 1 · Rhode Island 1 · Switzerland 1

Is Edmund F. Mrak Jr coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

7 documents, newest first
FirmOpen
483 CARBOGEN AMCIS AGDec 16, 2022 · Bubendorf, Switzerland
483 Form 483 · FEI 3002889358Aug 25, 2022 · Branchburg, New Jersey
483 Alexion Pharmaceuticals, IncAug 3, 2016 · Smithfield, Rhode Island
483 Kumar Organic Products LimitedMay 13, 2016 · Bangalore, India
483 Ocular Therapculix, IncFeb 5, 2016 · Bedford, Massachusetts
483 Central Admixture Pharmacy Services, Inc.Feb 20, 2014 · Woburn, Massachusetts
483 Exemplar Pharmaceuticals LLCMar 21, 2012 · Fall River, Massachusetts

About this profile

What does Edmund F. Mrak Jr inspect?

Edmund F. Mrak Jr appears on 7 documents on file covering 7 sites, most often in Massachusetts.

What do they cite most often?

21 CFR 211.160 (general requirements), followed by 21 CFR 211.42 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Edmund F. Mrak Jr is dated Dec 16, 2022.